Position in GUTS
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$7,152
New position
Shares Held
15,617
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Wealthspire Advisors, LLC holds $11,039,371 across 15 Biotechnology names. GUTS ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,706 | $6,726,603 | |
| 2 | GALT |
Galectin Therapeutics Inc
|
721,788 | $2,013,788 | |
| 3 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
34,359 | $850,728 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
895 | $399,653 | |
| 5 | MREO |
Mereo BioPharma Group plc
|
796,036 | $262,691 | |
| 6 | RNXT |
RenovoRx, Inc.
|
252,525 | $255,050 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,683 | $200,853 | |
| 8 | OLMA |
Olema Pharmaceuticals, Inc.
|
10,172 | $151,664 |
All Filings in GUTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,152 | 15,617 | Shares | Sole | 2026-05-01 | |
| No filing history on record for this holder in this stock. | ||||||